论文部分内容阅读
说起多发性肌炎,患者和医生都知道这是医学界公认的疑难病,不少病人的病情得不到有效的控制。随着发病因素的增加和诊断手段的提高,被确认为多发性肌炎的病人也呈上升趋势。多发性肌炎到底是一种什么样的疾病,和一般的炎症有什么区别?怎样才能使一个个灰冷绝望的心灵踏上希望之路?带着这些疑问,笔者走访了石家庄开发区医药研究所附属医院副院长张庆昌主任医师。 张庆昌六十年代末期毕业于天津中医学院,30余年的从医路有一半的行程与多发性肌炎的临床与实验
Speaking of polymyositis, patients and doctors all know this is the medical profession recognized difficult problems, many patients with the disease can not be effectively controlled. With the increase of the risk factors and the improvement of the diagnostic methods, the patients confirmed as polymyositis are also on the rise. What kind of disease polymyositis in the end is what kind of disease, and the general inflammation What is the difference? How to make a desperate soul on the path of hope? With these questions, the author visited the pharmaceutical research in Shijiazhuang Development Zone Affiliated Hospital Vice President Zhang Qingchang chief physician. Zhang Qingchang graduated from the Tianjin Institute of Chinese Medicine in the late 1960s, more than 30 years of medical practice, half of the trip and polymyositis clinical and experimental